The combination drug valsartan/sacubitril (LCZ696) reduced pulse wave velocity and aortic systolic blood pressure in patients with stable heart failure with reduced ejection fraction

Authors
Kobalava Z. , Villevalde S. , Tyukhmenev E. , Lukina O.O. , Babaeva L. , Zharikova E.
Publisher
Elsevier Science Publishing Company, Inc.
Language
English
Pages
335-335
Status
Published
Volume
18
Year
2016
Date of creation
19.10.2018
Date of change
08.02.2022
Short link
https://repository.rudn.ru/en/records/article/record/7959/
Share

Other records